卫报·· 6 天前AI 评分14
FTC and seven states seek contempt ruling against Shkreli over pharma ban
FTC and seven states seek contempt ruling against Shkreli over pharma ban
AI 导读
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisionsThe Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on p
来源：卫报 · theguardian.com